Switzerland eases access to prescription medicines
This article was originally published in OTC Bulletin
Swiss consumers will soon be able to buy a number of prescription-only medicines without a prescription through pharmacy – such fluticasone, ketotifen and desloratadine – following the latest revisions to the country’s medicines regulation, the HMG.
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.